F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comCamlin Fine Sciences Ltd (CFS) is a well-known global player in the specialty chemicals and antioxidants segment. The company supplies high-quality shelf-life solutions, aroma ingredients, and performance chemicals to food, pet food, pharmaceutical, and industrial markets worldwide. With a broad international footprint and growing demand for antioxidants, investors are increasingly tracking the long-term potential of CFS.
In this article, we examine Camlin Fine Sciences Ltd’s share price target from 2025 to 2030, supported by current performance, fundamentals, and business outlook.
Below are the latest stock metrics based on the most recent trading session:
| Detail | Value |
|---|---|
| Open | ₹171.97 |
| Previous Close | ₹170.65 |
| Day's High | ₹172.14 |
| Day's Low | ₹164.65 |
| VWAP | ₹167.50 |
| Volume | 6,17,630 |
| Value (Lacs) | 1,023.23 |
| Market Cap | ₹3,114 Cr |
| Beta | 1.37 |
| 52-Week High | ₹333.30 |
| 52-Week Low | ₹112.70 |
| All-Time High | ₹333.30 |
| All-Time Low | ₹33.00 |
| UC Limit | ₹187.71 |
| LC Limit | ₹153.58 |
| Face Value | ₹1 |
| Book Value Per Share | ₹48.65 |
| 20D Avg Volume | 6,49,312 |
| 20D Avg Delivery | 62.26% |
The stock shows high volatility (1.37 beta) and strong delivery percentages, indicating strong investor interest in accumulation zones.
Camlin Fine Sciences specializes in manufacturing high-quality antioxidants, aroma chemicals, and performance chemicals. The company supplies globally to over 80 countries, especially across the food and animal nutrition industries.
Key strengths include:
Strong presence in global antioxidant market
Integrated manufacturing facilities
Wide product portfolio including shelf-life solutions
Consistent export demand
Strong reputation for quality and research capability
By focusing on specialty chemicals, fragrances, and bio-technology-driven ingredients, CFS aims to capture a larger share of global chemical value chains.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 49.08% |
| Retail & Others | 43.33% |
| Mutual Funds | 4.77% |
| Foreign Institutions | 2.12% |
| Other Domestic Institutions | 0.71% |
The high retail participation shows strong public interest, while nearly 50% promoter holding reflects long-term commitment to the business.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 185 | 210 |
| 2026 | 210 | 240 |
| 2027 | 240 | 275 |
| 2028 | 275 | 310 |
| 2029 | 300 | 340 |
| 2030 | 330 | 380 |
These projections reflect business expansion, margin improvements, global demand for antioxidants, and the company’s focus on high-value specialty products.
By 2025, demand for antioxidants, aroma ingredients, and performance chemicals is expected to grow steadily.
Reasons:
Recovering chemical prices
Increased food and pet-food consumption
Steady export market performance
Investment View: Ideal for accumulation for long-term investors.
In 2026, manufacturing expansion and better capacity utilization may drive revenue growth.
Reasons:
New product developments
Stronger global client relationships
Higher ARPU in aroma chemicals
Investment View: Hold with a long-term perspective.
The company may improve margins through integration and cost optimization.
Reasons:
Lower raw material dependency
Strategic backward integration
Expanding footprint in specialty fragrance compounds
Investment View: Suitable for growth-oriented portfolios.
By 2028, CFS may benefit from expansion of its shelf-life solution business and rising demand for food stabilizers.
Reasons:
Wider global distribution networks
Improved profitability
Growth in nutraceutical and pet-food sectors
Investment View: Good long-term compounding potential.
Demand for performance chemicals and better export margins can fuel strong upward movement.
Reasons:
Higher capacity utilization
Increase in global industrial chemical demand
Expansion of aroma chemical line
Investment View: Attractive for long-term investors seeking stability and growth.
By 2030, CFS may emerge as a major global supplier of antioxidants and specialty chemicals.
Reasons:
Strong global market positioning
Enhanced manufacturing capabilities
High promoter confidence and R&D investment
Investment View: Strong choice for long-term wealth creation.
Camlin Fine Sciences Ltd is well-positioned to benefit from rising demand for antioxidants, shelf-life solutions, and aroma ingredients across global markets.
Reasons to consider investing:
Strong global presence
High-value specialty chemical portfolio
Rising demand in food, pharma, and industrial sectors
Improved financial efficiency in recent years
Risks to consider:
High price volatility due to market cycles
Sensitivity to raw material costs
Slowdown in demand from global manufacturing
Camlin Fine Sciences Ltd is a promising specialty chemicals company with a strong global presence and a diversified product portfolio. With steady demand for antioxidants and aroma chemicals, the share price shows potential to move toward ₹380 by 2030, provided business growth and profitability trends continue.
This article is for educational and example purposes only. Always consult a financial advisor before making investment decisions.
Register & Login